The Encapsulation of Febuxostat into Emulsomes Strongly Enhances the Cytotoxic Potential of the Drug on HCT 116 Colon Cancer Cells

Febuxostat (FBX) is a drug able to inhibit xanthine oxidase and reduce uric acid production commonly used for the treatment of hyperuricemia in subjects suffering from gout. Several studies have also been directed at its use as anti-cancer drug during the last years, opening a window for its off-lab...

Descripción completa

Detalles Bibliográficos
Autores principales: Fahmy, Usama A., Aldawsari, Hibah M., Badr-Eldin, Shaimaa M., Ahmed, Osama A. A., Alhakamy, Nabil A., Alsulimani, Helal H., Caraci, Filippo, Caruso, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600960/
https://www.ncbi.nlm.nih.gov/pubmed/33050567
http://dx.doi.org/10.3390/pharmaceutics12100956

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600960/
https://www.ncbi.nlm.nih.gov/pubmed/33050567
http://dx.doi.org/10.3390/pharmaceutics12100956

Ejemplares similares